FAQs

What is included in a CPD Report™?

Each PharmD Report includes an explanation of detected pathogens and resistance genes, clinical interpretations of results, and clear therapeutic guidance written in practical, provider-friendly language. The report is reviewed by a clinical pharmacist and appended to your lab’s existing report for a complete, unified output.

Sensitivity tables are an optional add-on that provides a comprehensive list of medications with antimicrobial activity for detected pathogens, taking into account resistance genes detected. This feature provides additional treatment options in the case the patient may require a medication not listed in the table (i.e. IV options due to severity of disease).

Yes. Our dosage tables include adjustments for renal function and age. When additional clinical information is available—such as allergies, concomitant medications, or prior antibiotic exposure—we incorporate it into the recommendation process.

Our Stewardship Reports provide a detailed breakdown of your lab’s detection rates which are compared to our network of labs. Additionally, clinic stewardship reports may be provided upon request.

Yes. Each report includes a QR code that connects providers to a live, trained pharmacist who can answer case-specific questions or clarify therapeutic recommendations.

We use advanced clinical algorithms developed by pharmacists and physicians, but every single report is manually reviewed by a PharmD before delivery. This ensures accuracy, efficiency, and clinical soundness.

We support PCR, multiplex panels, and other molecular diagnostics, including respiratory, UTI, GI, wound, STI, women’s health, nail, and ENT panels. Custom panels can also be supported depending on your LIS setup.

Treatment recommendations are based on aggregate of data, including clinical practice guidelines (IDSA, CDC, WHO, AAP), primary and secondary literature (randomized controlled trials, meta-analyses, PubMed), and tertiary references (Sanford Guide, Micromedex, Clinical Pharmacology).

Following submission of lab results, our average turnaround time (TAT) is approximately 10 minutes during business hours and 15 minutes during evening hours.

The PharmD report is transmitted as a PDF and is typically combined with the lab report resulting in a single PDF. This creates a comprehensive report, featuring laboratory results along with therapeutic guidance. The PharmD report can be positioned either at the beginning or the end of the lab report, based on preference.

Yes, we establish a robust HL7 integration with your lab’s Laboratory Information System (LIS) to ensure seamless and efficient data transmission. This integration allows for the automated exchange of information, streamlining workflows and reducing the risk of errors. By facilitating smooth communication between your lab and our software, we enhance the overall efficiency and accuracy of the reporting process.

After your lab completes sample results, the data will be transmitted to Choice PharmD through an HL7 message. Our pharmacists will review the information and prepare a detailed PharmD report for each result. A PDF will then be securely sent back to your Laboratory Information System (LIS) via Secure File Transfer Protocol (SFTP) and seamlessly appended to your lab’s results.